Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R England

Showing results (271-280 of 328) with videos related to

Pageof 33
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 5, 2020
Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific AutoantibodiesTed R Mikuls, Jess Edison, Elizabeth Meeshaw, et al.
Arthritis Care & Research|April 6, 2026
Associations of Rheumatoid Arthritis Disease Activity with Frailty Over Five Years of Follow-upCourtney N Loecker, Yangyuna Yang, Punyasha Roul, et al.
Seminars in Arthritis and Rheumatism|April 14, 2023
Enhancing the identification of rheumatoid arthritis-associated interstitial lung disease through text mining of chest computerized tomography reportsBrent A Luedders, Brendan J Cope, Daniel Hershberger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 13, 2025
Associations of Fire Smoke and Other Pollutants With Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung DiseaseVanessa L Kronzer, Yangyuna Yang, Punyasha Roul, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2025
ReplyVanessa L Kronzer, Yangyuna Yang, Punyasha Roul, et al.
Rheumatology (Oxford, England)|April 4, 2022
The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung diseaseRebecca Brooks, Joshua F Baker, Yangyuna Yang, et al.
The Lancet. Rheumatology|January 10, 2025
Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort studyBryant R England, Joshua F Baker, Michael D George, et al.
International Immunopharmacology|May 2, 2021
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohortBryant R England, Megan Campany, Harlan Sayles, et al.
Rheumatology (Oxford, England)|March 24, 2022
Elevations in adipocytokines and mortality in rheumatoid arthritisJoshua F Baker, Bryant R England, Michael D George, et al.
Seminars in Arthritis and Rheumatism|April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user studyHalie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Pageof 33

Showing results (271-280 of 328) with videos related to

Sort By:
Pageof 33
Arthritis & Rheumatology (Hoboken, N.J.)|July 5, 2020
Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific AutoantibodiesTed R Mikuls, Jess Edison, Elizabeth Meeshaw, et al.
Arthritis Care & Research|April 6, 2026
Associations of Rheumatoid Arthritis Disease Activity with Frailty Over Five Years of Follow-upCourtney N Loecker, Yangyuna Yang, Punyasha Roul, et al.
Seminars in Arthritis and Rheumatism|April 14, 2023
Enhancing the identification of rheumatoid arthritis-associated interstitial lung disease through text mining of chest computerized tomography reportsBrent A Luedders, Brendan J Cope, Daniel Hershberger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 13, 2025
Associations of Fire Smoke and Other Pollutants With Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung DiseaseVanessa L Kronzer, Yangyuna Yang, Punyasha Roul, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2025
ReplyVanessa L Kronzer, Yangyuna Yang, Punyasha Roul, et al.
Rheumatology (Oxford, England)|April 4, 2022
The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung diseaseRebecca Brooks, Joshua F Baker, Yangyuna Yang, et al.
The Lancet. Rheumatology|January 10, 2025
Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort studyBryant R England, Joshua F Baker, Michael D George, et al.
International Immunopharmacology|May 2, 2021
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohortBryant R England, Megan Campany, Harlan Sayles, et al.
Rheumatology (Oxford, England)|March 24, 2022
Elevations in adipocytokines and mortality in rheumatoid arthritisJoshua F Baker, Bryant R England, Michael D George, et al.
Seminars in Arthritis and Rheumatism|April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user studyHalie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Pageof 33